Clinical Trials
14 trialsNCT02484677 2023-05-26
5-FU
Assistance Publique Hopitaux De Marseille
Phase 4 Completed
NCT02549677 2022-10-27
ELEGANT
Ruijin Hospital
Phase 4 Completed
NCT02419742 2022-10-12
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
Phase 4 Completed
NCT02502864 2020-09-11
Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide
H. Lee Moffitt Cancer Center and Research Institute
Phase 4 Completed
NCT02445586 2019-10-29
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01094184 2018-03-22
BATMAN
Hoffmann-La Roche
Phase 4 Completed
NCT02088515 2017-03-03
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 4 Completed
NCT01301729 2016-12-29
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
Hoffmann-La Roche
Phase 4 Completed
NCT01660542 2016-11-01
An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer
Yonsei University
Phase 4 Completed
NCT00883675 2013-12-18
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Maestro Clinical, Inc.
Phase 4 Completed
NCT01442909 2011-09-29
Pemetrexed Followed by Docetaxel or in Reverse Sequence
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed
NCT00127933 2011-08-10
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00280098 2009-12-07
Docetaxel in the Treatment of Hormone Refractory Prostate Cancer
Sanofi
Phase 4 Completed
NCT00772681 2009-12-07
Tax-Nazo
Sanofi
Phase 4 Completed